213 related articles for article (PubMed ID: 22919678)
1. Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.
Gutting BW; Nichols TL; Channel SR; Gearhart JM; Andrews GA; Berger AE; Mackie RS; Watson BJ; Taft SC; Overheim KA; Sherwood RL
Front Cell Infect Microbiol; 2012; 2():87. PubMed ID: 22919678
[TBL] [Abstract][Full Text] [Related]
2. Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit.
Gutting BW; Marchette D; Sherwood R; Andrews GA; Director-Myska A; Channel SR; Wolfe D; Berger AE; Mackie RS; Watson BJ; Rukhin A
J Theor Biol; 2013 Jul; 329():20-31. PubMed ID: 23567649
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
[TBL] [Abstract][Full Text] [Related]
6. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
[TBL] [Abstract][Full Text] [Related]
7. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
8. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
9. Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).
Lever MS; Stagg AJ; Nelson M; Pearce P; Stevens DJ; Scott EA; Simpson AJ; Fulop MJ
Int J Exp Pathol; 2008 Jun; 89(3):171-9. PubMed ID: 18460069
[TBL] [Abstract][Full Text] [Related]
10. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores.
Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA
PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.
Mytle N; Hopkins RJ; Malkevich NV; Basu S; Meister GT; Sanford DC; Comer JE; Van Zandt KE; Al-Ibrahim M; Kramer WG; Howard C; Daczkowski N; Chakrabarti AC; Ionin B; Nabors GS; Skiadopoulos MH
Antimicrob Agents Chemother; 2013 Nov; 57(11):5684-92. PubMed ID: 23979731
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.
Fellows PF; Linscott MK; Ivins BE; Pitt ML; Rossi CA; Gibbs PH; Friedlander AM
Vaccine; 2001 Apr; 19(23-24):3241-7. PubMed ID: 11312020
[TBL] [Abstract][Full Text] [Related]
13. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
[TBL] [Abstract][Full Text] [Related]
14. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.
Zaucha GM; Pitt LM; Estep J; Ivins BE; Friedlander AM
Arch Pathol Lab Med; 1998 Nov; 122(11):982-92. PubMed ID: 9822127
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure therapy of inhalational anthrax in the common marmoset.
Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS
Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment.
Comer JE; Ray BD; Henning LN; Stark GV; Barnewall RE; Mott JM; Meister GT
Clin Vaccine Immunol; 2012 Sep; 19(9):1517-25. PubMed ID: 22837095
[TBL] [Abstract][Full Text] [Related]
17. Pathology of inhalational anthrax animal models.
Twenhafel NA
Vet Pathol; 2010 Sep; 47(5):819-30. PubMed ID: 20656900
[TBL] [Abstract][Full Text] [Related]
18. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
[TBL] [Abstract][Full Text] [Related]
19. Pathology and pathophysiology of inhalational anthrax in a guinea pig model.
Savransky V; Sanford DC; Syar E; Austin JL; Tordoff KP; Anderson MS; Stark GV; Barnewall RE; Briscoe CM; Lemiale-Biérinx L; Park S; Ionin B; Skiadopoulos MH
Infect Immun; 2013 Apr; 81(4):1152-63. PubMed ID: 23357384
[TBL] [Abstract][Full Text] [Related]
20. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
